Abstract

The effects of in vitro VIP administration and those of in ovo pretreatment with PACAP antagonist (PACAP6-38) on the development of the embryonic melatonin (MT) secretion were investigated. With dynamic in vitro bioassay we showed that (1) the development of the circadian MT secretion seems to be unaffected by VIP administrations or by PACAP6-38 pretreatments; (2) exposure of the embryonic chicken pineal gland to VIP induces transitory increase in MT secretion at or before the 14th embryonic day in vitro.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call